CASP1 and Hepatic fibrosis: We identified the NLRP3/Cleaved Caspase-1/IL-1β signaling in the liver to evaluate the impact of MP-40 on hepatic fibrosis and to clarify the mechanism of action of MP-40 in treating hepatic fibrosis.